May 21, 2014 by Arezu Sarvestani
Zimmer president & CEO David Dvorak is looking to avoid layoffs as much as possible following the pending mega-merger with long-time rival Biomet.
Both companies run their own independent distributor networks and Dvorak said he aims to keep both, expecting that the combined portfolio of Zimmer and Biomet products will provide “plenty for those sales reps to do.” Read more
May 23, 2014 by MassDevice
If you are part of either Zimmer or Biomet, whether as a direct employee or an independent contractor, congratulations on the big news last week. These are exciting times in orthopedics! But, now what? The phone-calls and emails have already started coming in from people on both sides wondering what to expect. What can you expect to happen and when?
No one has a crystal ball, but having been through the Stryker/Howmedica acquisition myself in 1999 and having watched many others, I can provide you a little insight into what you might expect to ensue over the months ahead. Read more
May 23, 2014 by Arezu Sarvestani
Embattled Echo Therapeutics issued a new volley against its proxy war rival and largest shareholder Platinum Group, accusing the activist investor of conspiring to tank the company’s stock.
Echo claimed today that a Platinum leader threatened the company’s former CEO via text message, adding that the investment had made some recent deals that hurt other stockholders while lining the company’s coffers. Read more